TAK
Takeda Pharmaceutical Company
DRUG MANUFACTURERS - SPECIALTY & GENERIC · HEALTHCARE
Takeda Pharmaceutical Company Limited (Ticker: TAK) is a prominent global biopharmaceutical firm based in Tokyo, Japan, that focuses on delivering innovative therapeutic solutions primarily in oncology, gastroenterology, and neuroscience. With a strong commitment to research and development, Takeda ...
$18.44
-1.65% ($0.31)
Volume
2.85M
52W High
$18.82
52W Low
$12.99
Market Cap
$47.54B
What to Watch This Quarter
Based on historical dataLast Quarter
$0.21
Current Streak
1 Miss
Avg Surprise (4Q)
+37,528.71%
Next Earnings Report
Reports in 69 days
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q4 2025
Jan 29, 2026
1-Day:
+0.35%
5-Day:
+1.51%
Q3 2025
Oct 30, 2025
1-Day:
+1.59%
5-Day:
+2.49%
Q2 2025
Jul 30, 2025
1-Day:
+0.88%
5-Day:
+4.85%
Q1 2025
May 8, 2025
1-Day:
+0.63%
5-Day:
-3.85%
Revenue & Financial Performance
Revenue Whisper
$1.15T
TWN Proprietary Estimate
Last Quarter Revenue
$1.21T
+6.0% YoY
Gross Margin
54.4%
Net Margin: 8.7%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $1.21T | +6.0% | 54.4% | 16.0% | $105.51B |
| Q3'25 | $1.11T | -5.4% | 65.9% | 6.2% | -$11.80B |
| Q2'25 | $1.11T | -8.4% | 65.2% | 16.7% | $124.24B |
| Q1'25 | $1.05T | +0.2% | 63.7% | -7.1% | -$103.20B |
| Q4'24 | $1.14T | +3.0% | 63.6% | 5.9% | $23.79B |
| Q3'24 | $1.18T | +12.8% | 66.5% | 15.7% | $92.05B |
| Q2'24 | $1.21T | +14.1% | 68.0% | 13.8% | $95.25B |
| Q1'24 | $1.05T | +9.9% | 63.1% | -1.0% | -$3.02B |
Company Information
Symbol
TAK
Company
Takeda Pharmaceutical Company
Market Cap
$47.54B
Sector
HEALTHCARE
Next Earnings
May 13, 2026
Also Reporting Soon
Companies reporting earnings around the same time as TAK
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - SPECIALTY & GENERIC
Compare TAK with competitors
Side-by-side earnings comparison